DCM
NBP

Discovery Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Discovery Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,200
Closed -$2.19M – 84
2021
Q4 		$2.19M Buy
+46,200
New +$2.77M 0.16% 60

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Discovery Capital Management's NBP Position: Q1 2022 in Review

Discovery Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 46,200 shares — an estimated $2.19M sold.

Discovery Capital Management first reported a position in NBP in Q4 2021 and held it in 1 quarter. The position peaked at $2.19M in Q4 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • Discovery Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Discovery Capital Management sold 46,200 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $2.19M.
  • Discovery Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Discovery Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $2.19M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Discovery Capital Management's 13F filing for Q1 2022, filed 16 May 2022.